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Abstract 
 
 
Introduction 
 
Doublecortin (DCX) is a microtubule associated protein expressed by migrating neural 
precursors. DCX is expressed in approximately 4% of all cortical cells in adult normal 
primate brain. DCX cells are is thought to play a role in plasticity or neural repair because 
their expression is enhanced locally in response to an acute insult made to the brain. That 
being said, it would be interesting to know how the expression of DCX is modified in stroke. 
The aim of my work is to study the expression of DCX cells in the cortex of patients having a 
stroke, compared to control patient. 
 
Methods 
 
DCX cells were quantified on DCX stained 5 μm thick formalin fixed paraffin embedded 
brain sections in 5 stroke patients and 3 control patients. .  By using a computerized image 
analysis system (Explora Nova, La Rochelle, France), cortical areas were selected on injured 
and perilesional areas. Total number of cells was counted, whereall nuclei were colored in 
blue. Then the DCX cells were counted on the corresponding 
DCX sections. The ratio of DCX cells over total cells was then calculated. 
 
Results 
 
We observed a similar ratio of DCX cells/total cells in the patients who died 1 day, 25 days 
and 1460 days after their stroke and in the control patients. However we found an important 
increase of the ratio DCX/total cells in the patients who died 2 and 13 days after stroke. In 
these two patients, the maximal amount of DCX cells could be observed in the perilesional 
areas. 
 
Discussion and conclusion 
 
The increase of DCX cells ration in patients died 2 and 13 days after stroke could be due to 
DCX cells being more resistant to degeneration after ischemia compared to surrounding cells. 
or to a recrutment of DCX cells, either from the cortical source of DCX cells or from the  
stem cell sub ventricular zone. 
In order to be able to answer this question, the total number should be counted, which is 
methodologically challenging. 
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Introduction 
 
Stem cells are undifferentiated cells that have the capacity to generate specialized cells and 
can divide to produce more stem cells.  
In mammals, there are three types of this cells; embryonic stem cells, foetal stem cells and 
adult stem cells.  
Embryonic stem cells are isolated from the blastocyte (4 days post fertilization). They create 
the three primary germ layers; ectoderm mesoderm and endoderm. Thus embryonic stem cells 
can produce all cell types of the adult body. We call this capacity totipotency.  
Foetal stem cells are the primitive stem cells in the organs of foetuses or umbilical cord and 
are less numerous than the embryonic ones. Unlike embryonic stem cells, these stem cells are 
not totipotent and are specific of the foetal tissue where they are found. They have a high 
level of division and important potential of differentiation. We say that they are multipotent
1
.  
Adult stem cells represent a few cells present in every tissue of the body. These cells have the 
capacity to repair and maintain the tissue in which they are found (multipotency). For 
example, neural stem cells can create all neural cells (neurons, astrocytes, oligodentrocytes). 
The formation of new neurons in the nervous system is called neurogenesis. Neurogenesis is 
more active during pre-natal development but it remains present in adulthood.  
There are in the human brain two distinct structures where neurogenesis remains during 
adulthood: the Sub-Ventricular Zone (SVZ) and the Sub-granular zone of the Dentate Gyrus
2
. 
Indeed, we observe in these two areas the generation of neurons from neural progenitor cells 
during adulthood. 
More recently the neurosurgical research group of the CHUV (Centre hospitalier universitaire 
vaudois) in Lausanne has been able to harvest cells originating from adult primates cortex of 
humans and monkeys
3
. These cultured cells are neural ecosystems with characteristics of 
precursor cells. However unlike stem cells, their rate of replication is more indolent and after 
a few weeks of culture, a senescence can be observed. Cortical Doublecortine (DCX) cells 
have been identified to be at the origin of these neuronal ecosystems. 
Doublecortin is a microtubule-associated protein that is transiently expressed in migrating 
neuroblasts in both developing and adult mammals, thus coordinating neuronal migration 
through the organization and stability of microtubules
4
. 
DCX was described for the first time
 5 as a gene X-linked Lissencephaly and Doublecortex 
Syndrome, which are two human disorders with a disruption of cortical neuronal migration 
during development. Neuronal precursors express DCX over a period of about two or three 
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weeks until they matured into neurons. A high concentration of DCX cells has been found in 
the neurogenesis areas, Sub-Ventricular Zone and in the Hippocampus, so DCX in those areas 
reflect neurogenesis
6
.
 
However, not only DCX cells are expressed in those specific locations 
in the adult, but they are also spread in the whole neo-cortex of adult human and non-human 
primates. Approximately 4.5% of all cortical cells express Doublecortin
3
. 
 
The fact that the brain has the capacity to generate new neurons raises the question of how 
neurogenesis is affected after a brain injury. For example, stroke is an acute brain damage 
caused by a stop of blood supply, representing a leading cause of neurological disability in 
humans.
7 
Recovery after stroke is long and often incomplete. 
The role of neural stem cells and precursor cells is not completely elucidated but is certainly 
crucial to help the patient recovering after stroke. Indeed, we observe in rodent with ischemic 
stroke an increase of cells proliferation in the SVZ. 
11
 Thus, we can say that endogenous 
neural stem cells supply the injured adult brain with new neurons but this supply is not 
sufficient for all the patients to recover their entire motor capacities. 
7
 
Unlike neural stem cells, little is known about the destiny of DCX cells after a stroke.  
The team from Lausanne has already 
3 
demonstrated in monkeys that the neural ecosystems 
originating from the DCX could improve motor function recovery after having been 
reimplanted in the same individual close to a motor cortical lesion. Now the question is 
whether the cortical DCX cells naturally found in the cortex also participate to brain repair 
after a stroke.  
The aim of my study is to analyze the histological distribution, morphology and 
characterization of DCX-positive cells in the cortex of patients who died from an acute stroke, 
and to compare it with control healthy subjects. 
 
Material and Methods 
 
1. Material 
 
This report is based on 8 human brain tissues obtained from the Department of Pathology of 
the Lausanne University Hospital (CHUV) cells. All human material was acquired in 
accordance with the CHUV local ethical committee. This table summarized the clinical 
characteristics of each patient. 
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5 stroke patients 
Patients Time between 
stroke and death 
Cause of stroke Injured territory 
A100046 1 day Intern Carotid stenosis ( M1 segment) Sylvian artery territory 
A900227 2 days Proximal and distal vasospasm of anterior cerebral circulation Anterior céeréebral artery 
territory 
A080090 13 days Embolism of cerebral anterior artery and middle céeréebral artery Sylvian artery territory 
A800154 25 days Right sylvian artery thrombus Sylvian artery territory 
A900190 4 years Preoperative distributive shock (lung transplant) Junctional infarcts 
Table. 1: Clinical characteristics of stroke patients 
 
3 control patients (death related to another cause) 
Patient Cause of death  
A100154 Cardiac transplant 
A080172 Three vessels coronary disease 
A090018 Pancreatic adenocarcinoma with liver metastasis 
Table. 2: Clinical characteristics of control patients 
 
2. Methods 
 
Immunohistological characterization was done for DCX with AB 2253 guinea pig anti-DCX, 
(Milipore, Temecula, California, USA). The immunoreactions were revealed for 
immunohistochemistry with biotinylated secondary antibody (goat anti-guinea pig, Vector 
Burlingame, CA, USA) followed by the immunoperoxydase Vectastain Elite system (PK 
6100, Vector Laboratories) and DAB substrate kit (SK-4100, Vector Laboratories). The 
counterstaining was obtained with Mayer’s hematoxylin solution (MHS32, Sigma-Aldrich, 
Buchs, Switzerland), Cresyl violet acetate and hematoxylin solution Gill no. 2 (GH23, Sigma-
Aldrich, Buchs, Switzerland). The DAB immunostainings were observed under light 
microscope (BX40 Olympus).  
 
The protocol used for immunohistochemistry of DCX is as following:  
 
-the sections were dried at 52°C for 30 min to melt the paraffin 
-hydration of brain sections: sequentially histosolve by dipping back and forth 10 
times each in alcohol 100%, 95% and 70% 
-wash 1 time with tap water 
-wash 1 time quickly with Potassium phosphate buffer salt 10 mM, PH6.9 (KPBS) 1x 
-wash in KPBS 2x5 min 
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-put the sections in Tris buffer with Ethylenediaminetetraacetic acid, PH 9 (Tris‐EDTA) for 5 
min in microwave (500W) for antigen retrieval 
-wash 1 time quickly with KPBS 1x, then 2x5 min in KPBS 1x 
-put the sections in 3% H2O2 in oxygene peroxide (H2O) for 10 min for quenching 
-wash 1 time quickly with KPBS 1x, then 2x5 min in KPBS 1x 
-blocking: 30 min in KPBS‐Casein 0.25% + triton and normal goat serum (NGS) 5% 
-primary Antibody (guinea pig anti-DCX) overnight in KPBS‐Casein 
 0.25% + triton 0.3% at 4°C 
-wash half of monkey brain tissue quickly with KPBS 
-preparation of the Secondary Antibody (goat anti-guinea pig) at 1/400 μl in KPBS + monkey 
brain tissue overnight at 4°C 
-wash 2x quickly then for 2x10 min in KPBS 1x 
-secondary Antibody (goat anti-guinea pig) at 1/400 μl for 40 min at RT 
-wash 1x quickly then 2x5 min in KPBS 1x 
-apply the ABC solution of the ABC kit for 30 min 
-wash 1x quickly then 2x10 min in KPBS 1x 
-revelation with DAB kit for 20 min 
‐wash 1x with tap water, then 1x quickly under KPBS 1x, then 2x5 min in KPBS 1x 
‐dehydration of stained brain sections: sequentially dip back and forth 10x each in 
alcohol 70%, 94%, 100% and histoclear 
‐embedding with Eukitt 
 
 
Histological analysis 
 
The DCX marked cells were counted with the Mercator Software from Explora 
Nova, under the Olympus BX40 microscope. In each section, we randomly chose two areas 
within the lesion and two perilesional aeras. An injured area was a region with a lot of gliosis, 
less nuclei and an important extravasation of hematies around blood vessels.  
 
Once the segmentation for the nucleus was defined and the cell surface limits from 25-250 
μm2 were applied, total cell and DCX cells were manually counted. For these two results, a 
ration could be calculated.  
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Fig2: The arrows are showing DCX cells in a perilesional area.  
 
Fig3: The arrow is showing a DCX stained cells in an injured area. 
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Fig4: On each section, 2 injured areas and two perilesional aeras were randomly selected. Then these areas 
were separated into several parts. Total cells and DCX cells were manually counted in order to optain a ratio.   
 
Data analysis 
 
Results analysis was done on Microsoft Excel using basic statistics tool. 
Raw data was collected directly from the Mercator Software which automatically 
converted the values into a Microsoft Excel chart. Values of interest collected are: 
number of total cells, number of DCX cells. 
 
The percentage of DCX cells over total cells was then calculated. 
 
  
Results 
 
1. Optimization of staining technique 
 
 The first part of my study was to optimize the technique of DCX cells staining for an 
optimal counting. However, despite the fact that we applied the same protocol for each 
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section, we observe a heterogeneicity in staining. We decided to rate the quality of 
staining from 1 to 5 (1, being the weakest and the most diffuse staining, and 5, the 
strongest and cleanest staining). To simplify the description of the staining we decided 
to form 2 categories: 
 1-3: weak and diffuse staining  
 4-5 : strong staining  
 
The presence of diaminobenzidine crystals combined with iron ions was highlight because 
these elements could bias the counting. 
 
Stroke sections Quality of staining Comments 
A100046 1 Weak and diffuse staining 
A900227 4 Strong staining 
A080090 4 Strong staining 
A800154 2 Weak staining 
A900190  2 Presence Oydates Diaminobenzidine cristals combined with iron 
ions (presence of red blood corpuscules or hemolysis waste) 
 
Table3. : Staining characteristics for stroke patients 
 
Controls Sections Quality of staining Comments 
A100154 5 Strong staining 
A080172 5 Strong staining 
A090018 5 Strong staining 
Table 4: Staining characteristics for control patients 
 
2. DCX/total cells ratio 
 
We observed a similar ratio of DCX cells/total cells in the patients who died 1day, 25days and 
1460 days after their stroke and in the control patients. However we found an important 
increase of the ratio DCX/total cells in patient who died 2 and 13 days after stroke. In these 
two patients, the maximal amount of DCX cells could be observed in the perilesional areas. 
 
 Total 
cells/1 
Total 
cells/2 
DCX/1 DCX/2 DCX/Total 
cells/1 
DCX/Total 
cells/2 
Average Standard 
deviation 
A100154 195 1042 9 36 4,6% 3.4% 4% 0,84% 
A080172 289 457 11 18 3,8% 3,93% 3,86% 0,09% 
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A090018 276 378 27 42 6,8% 11,11% 8,95% 3,04% 
Table 5: DCX/total cell ratio in control patients 
Patient Total 
cells/1 
Total 
cells/2 
DCX/1 DCX/2 DCX/Total 
cells/1 
DCX/Total 
cells/2 
Average Standard 
deviation 
A100046 263 0 276 0 0% 0% 0% 0% 
A900227 183 136 17 35 9.23% 25.73% 17,48% 11,66% 
A080090 415 269 90 30 21,68% 11,15% 16,5% 7,44% 
A800154 606 705 12 8 1,98% 1,13% 1,55% 0,60% 
A900190 641 1150 7 17 1,09% 1,47% 1,28% 0,27% 
Table 6: DCX/total cell ratio in stroke patients (perilesional area) 
Patient Total 
cells/1 
Total 
cells/2 
DCX/1 DCX/2 DCX/Total 
cells/1(%) 
DCX/Total 
cells/2(%) 
Average Standard 
deviation 
A100046 493 1061 3 10 0,60% 0,94% 0,77% 0,24% 
A900227 120 124 30 91 25% 73,38% 49,19% 34,20% 
A080090 61 240 17 106 27,86% 44,16% 36,01% 5,76% 
A800154 576 319 2 7 0,34% 2,19% 1,26% 1,30% 
A900190 176 1180 11 18 6.25% 1,52% 3,88% 3,34% 
Table 7: DCX/total cell ratio in stroke patients (lesional area) 
 
 
 
Chart5Graph1: Time between death and stroke/DCX cells 
 
 
Discussion 
 
The first part of my study was to optimize the staining. Despite the fact that we applied in 
each section the same protocol, we saw a difference in the quality of staining between 
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sections. This heterogeneity could be explain by the fact that the sections given by the 
Department of Pathology of the Lausanne University Hospital were old sections stored since a 
long time ago with different preparation methods and different time between death and brain 
slicing. This long storage could explain the bad quality of RNA and that’s the reason why we 
couldn’t apply molecular techniques on these tissues.  
All these factors could have affected the quality of the staining. Furthermore, even if 
immunological detection is a very used method, it seems important to mention the fact that 
many factors could influence the fixation reproducibility. So we must consider every tissue 
individually, comparing injured and perilesional areas in each section. 
It is also important to consider the fact that, on a very damaged tissue, the antibody could not 
recognize the target anymore so that’s the reason why a tissue without any staining was 
excluded.  
However, the fact that the results confirm the same ratio in control patients of DCX 
cells over total cells as the one found in a previous study on non human primates
3
,  
4-5% shows that the results of this study could be reproductible.
 
Fig 5: Evolution of DCX ratio in a stroke area 
 
 
A: Patient died 1 day after stroke -> normal ratio 
 
In the section of cortex from the patient who died one day after the ischemic lesion, we did 
not see DCX cell proliferation. Several hypotheses could explain this result.  
 
First of all, it could be a false negative result because of the bad quality of the staining. 
In order to confirm or reject this hypothesis, we would have to find a section stained without 
the second antibody.   
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The second hypotheses could be that a latency is needed to see DCX cells close to a lesion. 
This can easily be explained by the fact that after a stroke, the DCX cells have to migrate a 
considerable distance to reach the lesion.  
 
B: Patient died 2 and 13 days after stroke -> increased ratio 
 
There are several hypotheses to explain the increase of DCX ration seen in patients who died 
2 and 13 days.  
 
First of all, it seems that DCX are much more numerous than nucleus. This observation could 
mean that DCX cells are “tougher” cells which resist neurodegeneration while non DCX cells 
around are degenerating. The question then would be why DCX cells aren’t degenerating and 
what makes those cells more resistant to neurodegeneration? This special robustness could be 
explained by the role of DCX cells which stabilize the microtubule for growth cone. 
 
To confirm this observation we would have to find a method to count the absolute number of 
total cells in both injured and control patients in a given volume, then count the absolute 
number of DCX cells to highlight a loss of total cells in stroke but no change in DCX cells 
number. This couldn’t be done in this study because the cortical thickness and the cell density 
was different from one patient’s section to the other depending on the localization of the 
section in the brain and the slicing plane of the brain tissue. This means that we couldn’t 
establish the cells absolute value. That’s why at this level we couldn’t confirm this 
hypothesis. 
 
The second interpretation to this DCX cell increase could be a recruitment of DCX cells 
towards the lesion. Here again, the only way to prove it would be to obtain the cell total count 
that should be increased compared to normal.  
 
The last hypothesis is that the DCX cells migrate from the SVZ, as previous
15
 studies seemed 
to demonstrate in rodent. However, since rodents don’t have DCX cells in their cortex, it is 
difficult to compare these results to the one observed in human brain. Furthermore, the 
distance between SVZ and the lesion cortex being very large, 48 hours seems to be a very 
short period of time to allow migration of DCX cells from the SVZ to reach the lesion.   
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C: Patients died 25 and 1460 days after stroke -> normal ratio 
 
First of all, the very low rate of DCX cells found in section of patient died 25 days and 4 
years after stroke could mean either that these cells disappeared or that the DCX cells 
transformed to mature cells.  
 
Here again the only way to prove it would be to obtain the total cell value. However 
considering our previous studies on autologous brain cell transplantation, we believe that 
these cells have the potential to differentiate to mature brain cells. 
Indeed, previous study 
3 
in monkey shows that stained DCX cells were becoming neurons.  
 
Here again the only way to prove it would be to obtain the total cell value. However 
considering our previous studies
3
 on autologous brain cell transplantation, we believe that 
these cells have the potential to differentiate to mature brain cells.  
 
This being said, it seems important to discuss about the role of DCX cells in stroke.   
In adult rodents, DCX+ cells are only found in the stem cell niches located in the 
subventricular zone and in the hippocampus. However the DCX cells can migrate from this 
niches to lesions elsewhere in the brain. It has also been demonstrated that the number of 
DCX+ cells positively correlates with the recovery of functional deficits after stroke. 
Furthermore, transgenic knockout DCX rodents exhibit worse outcome after a stroke both in 
the short and long term on a consistent basis
4,5
.
 
 
In non human primates, the conditions are different, since DCX cells are also found in the 
cortex. Nevertheless there is also a correlation between the DCX cells and stroke. Indeed a 
study
3 
showed an increase of neurogenesis after stroke that could be related to motor 
capacities improvement. However, no study could confirm these facts in humans. Therefore if 
the neuron increase is confirmed, it is still difficult to establish a clear link between new 
neurons and motor capacities improvement.  
 
A lot of questions are arising from my results, but they can’t be answered in this study 
which was limited due to time and several other factors. 
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Perspectives 
 
In our study DCX/total cell ratio changed depending on the time after stroke. However the 
number of sample we studied is small and to confirm the increase and decrease of DCX/total 
cell ration, we need to collect more data.  
  
It would be also interesting to observe and count the DCX cells not only close to the lesion 
site but also in the rest of the brain.  
 
Finally we could continue our observation and get more information about the distribution of 
the DCX cells within the different layers of the cortex. Moreover, knowing from our previous 
paper
15 
that cortical DCX cells are categorized in different subpopulations, we could also 
determine if one subtype of DCX subpopulation is more affected by these post stroke 
changes.  
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